Early identification of hERG liability in drug discovery programs by automated patch clamp.
about
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesA New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm.Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.Natural products modulating the hERG channel: heartaches and hope.Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1.What can nanosafety learn from drug development? The feasibility of "safety by design".Compilation and physicochemical classification analysis of a diverse hERG inhibition database.Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia.Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes.Reflective lens-free imaging on high-density silicon microelectrode arrays for monitoring and evaluation of in vitro cardiac contractility.
P2860
Q26883657-326C9937-A1D7-4B9D-BE28-C914807723DDQ38546437-9749672A-FF51-4369-80DE-814174DA91D6Q38671689-3ADC9FC5-BE7C-4AD7-BAF7-3614EB51C45DQ38684705-CDC1947C-A157-46FF-979C-7A0826237D84Q39169967-437E429D-78FE-40C9-9C5E-8EF49B87F63EQ39183378-FEA4A3BB-93CD-4C53-8E2E-2658D76AD7CEQ39248121-EA85286C-06B5-4F17-AF54-E825EAC8E098Q39378653-A4F21927-91BC-46DB-A41D-90FE83928621Q40050616-BC096E1B-8DF7-4EC2-834B-0D6261624242Q40460868-E81ED7A5-E6F8-4C30-8940-2E79A831A140Q47794241-8DA6B9A2-D91F-4CDD-BBB2-379A195CF77DQ55004016-5CD293AF-08B9-4AA7-8A23-8B60462A705E
P2860
Early identification of hERG liability in drug discovery programs by automated patch clamp.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Early identification of hERG l ...... rams by automated patch clamp.
@en
type
label
Early identification of hERG l ...... rams by automated patch clamp.
@en
prefLabel
Early identification of hERG l ...... rams by automated patch clamp.
@en
P2860
P356
P1476
Early identification of hERG l ...... rams by automated patch clamp.
@en
P2093
Clemens Möller
Timm Danker
P2860
P356
10.3389/FPHAR.2014.00203
P577
2014-09-02T00:00:00Z